Medtronic’s* strong enabling technology placements (Mazor X* robot, O-Arm imaging and StealthStation* navigation) in Q420 are seen as positive indicators of a post-pandemic recovery in CAS Spine. Enabling technology continues to help drive market share gains in addition to traditional implant development and commercial execution, with spine manufacturers across the industry incorporating enabling tech into their near-, mid- and long-term plans.
Among the many topics covered in the comprehensive Q420/FY20 CAS Spine Market Recap *are:
Medtronic estimates it continued to outsell in spine robotics in Q420 despite Globus’* record Excelsius GPS* sales with strong large capital equipment sales, setting a record on Mazor robot sales with near-records in O-arm imaging and StealthStation navigation system sales. The Company is having success with its Surgical Synergy strategy which is likely to continue as financially constrained hospitals seek ...
Read the entire Q420/FY20 CAS Spine Market Recap including news, data, charts, company revenues, shares and analysis*
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click here.
SmartTRAK is kicking off 2021 with some exciting new product launches, including Pediatric Spine. Click the button to see what we have on tap in the coming months.